Leflunomide in Dogs

Leflunomide is a prescription immunosuppressive medication that your vet may use in dogs with certain immune-mediated diseases. In plain language, it helps calm an overactive immune system when the body is attacking its own red blood cells, platelets, joints, skin, or other tissues. In dogs, it is used off-label, which means it is a human medication prescribed in a way that is common and legal in veterinary medicine but not specifically FDA-approved for dogs.

Your vet may reach for leflunomide when a dog needs more than one immune-calming medication, when steroid side effects are becoming hard to manage, or when another immunosuppressant is not working well enough. Reported veterinary uses include immune-mediated polyarthritis, immune-mediated hemolytic anemia, immune-mediated thrombocytopenia, and some immune-mediated skin conditions. Recent canine studies also support its long-term use in some dogs with immune-mediated polyarthritis, though monitoring remains important because side effects and liver enzyme changes can occur.

For many pet parents, the biggest practical questions are whether leflunomide is safe, how long it takes to work, and what monitoring is needed. The answer depends on the dog, the disease being treated, and what other medications are being used at the same time. Most dogs need baseline bloodwork before starting and repeat lab checks during treatment so your vet can watch for liver changes, low blood cell counts, infection risk, and overall response.

Leflunomide is not a medication to start, stop, or adjust on your own. If your dog seems weak, stops eating, vomits repeatedly, develops bruising, has yellowing of the gums or eyes, or seems to be getting sick while on treatment, contact your vet promptly. Because this drug suppresses the immune system, even mild changes can matter.

Leflunomide works by interfering with the ability of certain immune cells, especially activated lymphocytes, to multiply. After a dog takes the tablet, the body converts it to an active metabolite called teriflunomide. That metabolite blocks a key step in pyrimidine synthesis, which immune cells need to make DNA and RNA during rapid replication. The result is less immune-cell expansion and less inflammatory damage.

That mechanism makes leflunomide useful in diseases where the immune system is driving the problem. In a dog with immune-mediated polyarthritis, for example, the goal is to reduce immune attack inside the joints. In a dog with IMHA or IMTP, the goal is to reduce destruction of red blood cells or platelets. It is not an antibiotic, pain medication, or cure for the underlying immune tendency. Instead, it is one tool your vet may use to bring the disease under better control.

Leflunomide does not always create a dramatic overnight change. Some drug effects begin early, but visible clinical improvement may take days to weeks depending on the disease and whether other medications, such as prednisone, are being used at the same time. Because response can be gradual, your vet may pair it with another medication at first and then adjust the plan over time.

One more point matters for safety: the drug can stay in the body for a while, and its effects may last longer in dogs with liver or kidney disease. That is one reason your vet may be cautious about dose changes and may recommend follow-up bloodwork even if your dog seems to be doing well at home.

The most commonly reported side effects in dogs are digestive upset and low energy. Pet parents may notice decreased appetite, nausea, vomiting, diarrhea, or lethargy. Some dogs tolerate the medication well, while others need a dose adjustment, a switch in timing with meals, or a different treatment plan. In published canine reports, many side effects were mild and manageable, but they still deserve a call to your vet.

More serious concerns include liver irritation, abnormal blood counts, bleeding problems, and increased susceptibility to infection. Warning signs can include yellowing of the eyes or gums, unexplained bruising, blood in urine or stool, fever, coughing, weakness, or a dog that suddenly seems much more tired than usual. Because leflunomide suppresses the immune system, infections may be easier to pick up and harder to fight off.

Some side effects may be more likely when leflunomide is combined with other immunosuppressive drugs, especially prednisone, or with medications that can also stress the liver. In one recent study of dogs treated long term for immune-mediated polyarthritis, adverse effects were reported in about one-third of dogs, and liver enzyme elevations were more common in dogs receiving leflunomide with prednisone than in dogs receiving leflunomide with an NSAID. That does not mean the combination should never be used. It means monitoring matters.

See your vet immediately if your dog has trouble breathing, collapses, develops seizures, has severe vomiting or diarrhea, shows signs of jaundice, or has any bleeding. Do not stop or restart immunosuppressive medication without veterinary guidance unless your vet has already told you what to do in an emergency.

Leflunomide is given by mouth, usually as a tablet once daily, though the exact schedule and dose depend on your dog’s diagnosis, body weight, lab results, and response over time. Published canine studies commonly describe starting doses around 2 to 4 mg/kg by mouth once daily, with some authors recommending 3 to 4 mg/kg once daily for at least 6 weeks before making dose adjustments in dogs with immune-mediated polyarthritis. Your vet may choose a different plan based on the condition being treated and any other medications in the protocol.

This medication may be given with or without food. If your dog seems nauseated or vomits after a dose on an empty stomach, your vet may suggest giving future doses with food. If a dose is missed, give it when you remember unless it is close to the next scheduled dose. Do not double up unless your vet specifically tells you to. Because leflunomide is considered a hazardous drug, many clinics recommend handling tablets with care, using gloves, and avoiding direct handling if you are pregnant or nursing.

Monitoring is a major part of safe dosing. Your vet will often check a baseline complete blood count and chemistry panel, including liver enzymes, before starting treatment. Recheck timing varies, but early follow-up bloodwork is common after starting or changing the dose, followed by periodic monitoring during long-term use. If your dog has liver disease, kidney disease, a weakened immune system, or is taking several other medications, your vet may recommend closer follow-up.

Do not change the dose because your dog seems better or worse without checking in first. Improvement in immune-mediated disease can lag behind the start of treatment, and side effects can appear even after the first few doses went smoothly. The safest plan is a written medication schedule and a clear recheck plan with your vet.

Leflunomide can interact with other medications that suppress the immune system or affect the liver. Your vet will want a complete list of everything your dog takes, including prescriptions, supplements, probiotics, joint products, and over-the-counter items. Important caution areas include prednisone and other glucocorticoids, cyclosporine, azathioprine, mycophenolate, methotrexate, and other drugs that may increase infection risk or compound liver stress.

VCA also lists several medications and products that should be used with caution alongside leflunomide, including activated charcoal, cholestyramine, furosemide, loperamide, rifampin, terbinafine, theophylline, warfarin, and modified-live vaccines. Some of these can change drug handling in the body, while others raise concern because of bleeding risk, liver effects, or altered immune response. Vaccination plans may need to be adjusted while a dog is on immunosuppressive therapy.

This does not mean combinations are always unsafe. In fact, leflunomide is often intentionally combined with other medications in dogs with serious immune-mediated disease. The key is that the combination should be planned and monitored by your vet. If another clinic prescribes a new medication, tell them your dog is taking leflunomide before anything is added.

Call your vet if your dog starts a new medication and then develops vomiting, diarrhea, bruising, jaundice, fever, or unusual tiredness. Those signs may reflect the underlying disease, the leflunomide, the new medication, or the interaction between them.